as on December 13, 2025 at 1:37 am IST
Day's High
3.26%
Upside
52 Week's Low
52 Week's High
51.73%
Downside
48.68%
Upside
Check Cytek Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$631.7M
EPS (TTM)
0.015
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.73%
PE Ratio (TTM)
-42.62
Industry PE ratio
-0.35549019607843135
PEG Ratio
0EBITDA
-26.9M
Revenue (TTM)
196.8M
Profit Margin
-6.51%
Return On Equity TTM
-3.36%
Track how Cytek Biosciences Inc P/E has moved over time to understand its valuation trends.
Cytek Biosciences Inc in the last 5 years
Lowest (-114.59x)
September 30, 2023
Today (-42.62x)
December 12, 2025
Industry (-0.36x)
December 12, 2025
Highest (174.51x)
December 31, 2021
Today’s Price to Earnings Ratio: -42.62x
Compare market cap, revenue, PE, and other key metrics of Cytek Biosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $631.7M | NA | -42.62 | -6.51% | |
| BUY | $137.4B | 173.07% | 49.57 | 14.43% | |
| BUY | $135.3B | 52.01% | 46.49 | 12.07% | |
| BUY | $129.2B | -11.24% | 27.31 | 13.71% | |
| BUY | $213.3B | 15.19% | 15.38 | 31.88% |
The Cytek Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Cytek Biosciences Inc investment value today
Current value as on today
₹82,451
Returns
Returns from Cytek Biosciences Inc Stock
Dollar Returns*
₹6,563 (+6.56%)
Based on 12 analysts
75.00%
Buy
25.00%
Hold
0.00%
Sell
Based on 12 analysts, 75% of analysts recommend a 'BUY' rating for Cytek Biosciences Inc. Average target price of $5.75
Get share price movements and forecasts by analysts on Cytek Biosciences Inc.
What analysts predicted
14.61%UPSIDE
Target Price
$5.75
Current Price
$4.91
Analyzed by
12 Analysts
Target
$5.75
Cytek Biosciences Inc target price $5.75, a slight upside of 14.61% compared to current price of $4.91. According to 12 analysts rating.
Investment in Cytek Biosciences Inc Shares on INDmoney has grown by 5600.00% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:5600.00% versus previous 30 day period
Search interest for Cytek Biosciences Inc Stock has increased by 2883% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:2883% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -11.40M → -5.47M (in $), with an average increase of 53.1% per quarter
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 41.45M → 52.29M (in $), with an average increase of 10.9% per quarter
Price Rise
![]()
In the last 3 months, CTKB stock has moved up by 26.1%
Against Peers
![]()
In the last 1 year, Medtronic Plc has given 20.6% return, outperforming this stock by 43.8%
Against Peers
![]()
In the last 3 years, Boston Scientific Corp. has given 25.1% return, outperforming this stock by 81.4%
| Organisation | Cytek Biosciences Inc |
| Headquarters | 47215 Lakeview Boulevard, Fremont, CA, United States, 94538 |
| Industry | Healthcare |
| CEO | Dr. Wenbin Jiang Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Patrik Sebastian Jeanmonod | Head of Corporate Development Analytics |
Dr. Wenbin Jiang Ph.D. | President, CEO & Chairman of the Board |
Mr. William D. McCombe | Chief Financial Officer |
Dr. Ming Yan Ph.D. | CTO & Director |
Ms. Valerie T. Barnett J.D. | Chief Legal Officer & Corporate Secretary |
Dr. Philippe Busque Ph.D. | Senior Vice President of Global Sales & Services |
Cytek Biosciences Inc share price today is $4.91 as on . Cytek Biosciences Inc share today touched a day high of $5.07 and a low of $4.91.
Cytek Biosciences Inc share touched a 52 week high of $7.3 on and a 52 week low of $2.37 on . Cytek Biosciences Inc stock price today i.e. is trending at $4.91,which is 32.74% down from its 52 week high and 107.17% up from its 52 week low.
Cytek Biosciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Cytek Biosciences Inc (CTKB) shares with as little as ₹90.397 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹903.97 in Cytek Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Cytek Biosciences Inc share’s latest price of $4.91 as on December 13, 2025 at 1:37 am IST, you will get 2.0367 shares of Cytek Biosciences Inc. Learn more about
fractional shares .